
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Taylor Momsen explains why she quit 'Gossip Girl': 'I really didn't want to be there' - 2
Step by step instructions to Get a good deal on Your Rooftop Substitution Venture - 3
Involved Vehicles for Seniors: Track down the Best Picks for Solace and Unwavering quality - 4
Ancient fire discovery marks significant milestone in human history - 5
Vote In favor of Your #1 Compelling Female Producer
A Time of Careful Eating: Individual Tests in Nourishment
How to watch 'A Charlie Brown Christmas' for free in 2025
7 Strange Devices to Make Your Party Stick Out!
Can ICE agents detain U.S. citizens? What powers do they have to arrest people? Your most common questions answered.
Don't fall for it: These common tourist scams in Rome are easy to avoid if you know what you're looking for
Illegal entries into Germany halve over two years, border police say
Thousands of Walgreens nasal spray bottles recalled. See which ones.
Bolsonaro discharged from hospital and placed under house arrest
Stolen Renoir, Cézanne and Matisse were probably uninsured, market sources say












